Amos Maritan

Title: Amos Maritan: Innovator in Intracellular Antibodies

Introduction

Amos Maritan is a notable inventor based in Trieste, Italy. He has made significant contributions to the field of biotechnology, particularly in the development of intracellular antibodies. His innovative work has led to the creation of a patented method that enhances the understanding of antibody sequences.

Latest Patents

Amos Maritan holds a patent for a method of identifying at least one consensus sequence for an intracellular antibody (ICS). This patent involves several steps, including the creation of a database comprising sequences of validated intracellular antibodies, aligning these sequences according to Kabat, and determining the frequency of specific amino acids in the aligned antibodies. The method also includes selecting a frequency threshold value and identifying the most frequent amino acid at specific positions in the alignment. This patent represents a significant advancement in the field, with Maritan being credited for his innovative approach.

Career Highlights

Amos Maritan is associated with MRC SISSA - Scuola Internazionale Superiore di Studi Avanzati, where he has contributed to various research projects. His work has been instrumental in advancing the understanding of intracellular antibodies and their applications in biotechnology. Maritan's dedication to research and innovation has positioned him as a key figure in his field.

Collaborations

Amos Maritan has collaborated with esteemed colleagues such as Antonino Cattaneo and Michela Visintin. These collaborations have fostered a productive research environment, leading to advancements in the study of intracellular antibodies.

Conclusion

Amos Maritan's contributions to the field of biotechnology, particularly through his patented method for identifying intracellular antibodies, highlight his role as an innovator. His work continues to influence research and development in this important area of study.